Your browser doesn't support javascript.
loading
Gp130 degradation induced by epirubicin contributes to chemotherapy efficacy.
Liu, Fangming; Jin, Haizhen; Shen, Jinhong; Wu, Dan; Tian, Ye; Huang, Chao.
Affiliation
  • Liu F; Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China.
  • Jin H; The Central Lab at Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Shen J; Institute of Health Sciences, Chinese Academy of Sciences-Jiaotong University School of Medicine, 320 Yueyang Road, Shanghai, 200031, China.
  • Wu D; The Central Lab at Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Tian Y; Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, China. Electronic address: tianye166@126.com.
  • Huang C; Thoracic Oncology Institute at Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. Electronic address: c_huang_bio@msn.com.
Biochem Biophys Res Commun ; 519(3): 572-578, 2019 11 12.
Article in En | MEDLINE | ID: mdl-31537377
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Epirubicin / Cytokine Receptor gp130 / Antibiotics, Antineoplastic Limits: Humans Language: En Journal: Biochem Biophys Res Commun Year: 2019 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Epirubicin / Cytokine Receptor gp130 / Antibiotics, Antineoplastic Limits: Humans Language: En Journal: Biochem Biophys Res Commun Year: 2019 Type: Article Affiliation country: China